Patient Capital Management’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.1M | Sell |
16,268,741
-1,103,560
| -6% | -$1.57M | 1.04% | 32 |
|
2025
Q1 | $25.9M | Sell |
17,372,301
-508,945
| -3% | -$758K | 1.33% | 30 |
|
2024
Q4 | $20M | Sell |
17,881,246
-56,448
| -0.3% | -$63.2K | 0.92% | 32 |
|
2024
Q3 | $17M | Sell |
17,937,694
-236,964
| -1% | -$224K | 0.83% | 34 |
|
2024
Q2 | $28.7M | Buy |
18,174,658
+721,203
| +4% | +$1.14M | 1.53% | 28 |
|
2024
Q1 | $25.3M | Buy |
17,453,455
+1,469,755
| +9% | +$2.13M | 1.23% | 34 |
|
2023
Q4 | $21.4M | Buy |
15,983,700
+2,230,524
| +16% | +$2.99M | 1.13% | 32 |
|
2023
Q3 | $19.5M | Buy |
13,753,176
+2,509,616
| +22% | +$3.56M | 1.15% | 34 |
|
2023
Q2 | $12.9M | Buy |
11,243,560
+9,779,800
| +668% | +$11.2M | 0.72% | 33 |
|
2023
Q1 | $1.55M | Buy |
1,463,760
+665,560
| +83% | +$705K | 0.69% | 37 |
|
2022
Q4 | $1.21M | Buy |
798,200
+500,000
| +168% | +$760K | 0.59% | 38 |
|
2022
Q3 | $632K | Hold |
298,200
| – | – | 0.32% | 40 |
|
2022
Q2 | $400K | Hold |
298,200
| – | – | 0.18% | 40 |
|
2022
Q1 | $629K | Hold |
298,200
| – | – | 0.21% | 42 |
|
2021
Q4 | $1.11M | Buy |
+298,200
| New | +$1.11M | 0.32% | 38 |
|